Dana Patsch

2.5k total citations
5 papers, 126 citations indexed

About

Dana Patsch is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dana Patsch has authored 5 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 1 paper in Molecular Biology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Dana Patsch's work include Cancer Immunotherapy and Biomarkers (3 papers), Viral-associated cancers and disorders (2 papers) and CAR-T cell therapy research (2 papers). Dana Patsch is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Viral-associated cancers and disorders (2 papers) and CAR-T cell therapy research (2 papers). Dana Patsch collaborates with scholars based in United States. Dana Patsch's co-authors include Rosemarie Mick, Amit Maity, John P. Christodouleas, Lilie L. Lin, Stephen M. Hahn, John N. Lukens, Tara C. Mitchell, Andy J. Minn, Robert H. Vonderheide and Lynn M. Schuchter and has published in prestigious journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and JAMA Oncology.

In The Last Decade

Dana Patsch

5 papers receiving 126 citations

Peers

Dana Patsch

ONCOL

IMMUN

PRM

MB

RNMI

Keisuke Onoi Japan

Alexandre Wicky Switzerland

William Le United States

James Good United Kingdom

Dalia Alqunaibit United States

Jennifer Friedmann Canada

Benjamin Shum United Kingdom

L. Resano Spain

Alexandra P. Cadena United States

Judith Sirokay Germany

Keisuke Onoi Japan

Dana Patsch

114 ×1.2

ONCOL

42 ×1.0

IMMUN

72 ×2.1

PRM

23 ×0.8

MB

16 ×1.0

RNMI

Citations per year, relative to Dana Patsch Dana Patsch (= 1×) peers Keisuke Onoi

Countries citing papers authored by Dana Patsch

Since Specialization

Citations

This map shows the geographic impact of Dana Patsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Patsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Patsch more than expected).

Fields of papers citing papers by Dana Patsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Patsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Patsch. The network helps show where Dana Patsch may publish in the future.

Co-authorship network of co-authors of Dana Patsch

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Patsch. A scholar is included among the top collaborators of Dana Patsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Patsch. Dana Patsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Maity, Amit, Rosemarie Mick, Ramesh Rengan, et al.. (2021). A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes. OncoImmunology. 10(1). 1863631–1863631. 18 indexed citations

2.

Rengan, Ramesh, Rosemarie Mick, Daniel A. Pryma, et al.. (2019). Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non–Small Cell Lung Cancer. JAMA Oncology. 5(10). 1464–1464. 26 indexed citations

3.

Maity, Amit, Rosemarie Mick, Alexander C. Huang, et al.. (2018). A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. British Journal of Cancer. 119(10). 1200–1207. 79 indexed citations

4.

Mick, Rosemarie, Sangeeth M. George, Michael D. Farwell, et al.. (2018). A Phase I Trial of Pembrolizumab with Hypofractionated Radiation Therapy (HFRT) in Patients with Metastatic Cancers. International Journal of Radiation Oncology*Biology*Physics. 102(3). S25–S25. 1 indexed citations

5.

Rengan, Ramesh, Rosemarie Mick, Daniel A. Pryma, et al.. (2018). Long-term Results of a Phase I/II Trial of Nelfinavir with Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). S19–S19. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact